FINWIRES · TerminalLIVE
FINWIRES

サバリア社、2030年末までに売上高16億ドルを目指す

-- サバリア(SIS.TO)は火曜日、今後5年間で売上高を年率12%増加させ、2030年末までに16億ドルに達することを目標としていると発表した。 同社は、サバリア・ワン・フレームワークに基づく5カ年財務目標の最新情報を発表し、調整後EBITDAマージンを20%に維持すると述べた。これにより、2030年までに1株当たり調整後EBITDAは4.25ドルに増加する見込みだと声明で述べた。 サバリアは2023年に、事業全体の価値を引き出すための変革計画「サバリア・ワン」を開始した。同社によると、このプログラムにより、2025年には売上高9億1350万ドル、調整後EBITDAマージン20%超を達成したという。 サバリアは、第1四半期の売上高を7%増の2億3500万ドルと見込んでいる。調整後EBITDAは4,800万ドルと見込まれており、前年比18%増、調整後EBITDAマージンは20%となる見込みです。 同社は本日、2回目の投資家向け説明会を開催します。 「本日の投資家向け説明会で申し上げたいのは、過去3年間はサバリアにとって歴史的な時期だったということです。私たちは、人材とプロセスに、これまでになかったような大規模な投資を行いました。私たちの事業の多くの側面を評価し、改善するために時間と労力を費やすことは、大規模な住宅リフォームのようなものです。私たちは一切妥協せず、最善を尽くしました。その結果、今後何年も使える、非常に堅牢でしっかりとした家が完成しました」と、マルセル・ブラッサ会長は述べています。 サバリア株は月曜日、トロント証券取引所で0.22ドル安の29.95ドルで取引を終えました。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB